Enterprise Value
57.92M
Cash
78.3M
Avg Qtr Burn
-12.2M
Short % of Float
0.83%
Insider Ownership
13.36%
Institutional Own.
61.95%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DB-OTO Details Hearing loss | Phase 1/2 Initiation | |
DB-020 Details Hearing loss | Phase 1b Update |